Valuation: Kenvue Inc.

Market Cap 36.94B 32.11B 29.89B 27.44B 51.82B 3,526B 52.63B 352B 138B 1,756B 139B 136B 5,887B P/E 2026 *
20.2x
P/E 2027 * 18x
Enterprise Value 44.35B 38.55B 35.88B 32.94B 62.21B 4,233B 63.18B 423B 166B 2,108B 167B 163B 7,067B EV / Sales 2026 *
2.84x
EV / Sales 2027 * 2.73x
Free-Float
98.9%
Yield 2026 *
4.4%
Yield 2027 * 4.49%
1 day-0.36%
1 week-0.21%
1 month-0.47%
3 months+10.38%
6 months+10.57%
Current year+11.54%
1 week 18.95
Extreme 18.95
20.05
1 month 18.58
Extreme 18.58
20.13
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
22.28
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap.
5/1/26 Fiscal year

Group President LATAM

55,637 0.0029%
3/30/26 Free

Director

1,331 0.0001%
2/13/26 Fiscal year

Chief Operating Officer

64,111 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
-0.36%-0.21%-10.88%-18.65% 36.94B
+0.37%-1.98%-4.09%-7.53% 336B
-2.21%+3.66%-6.95%+0.35% 137B
-0.33%+0.61%+9.33%+19.13% 72.78B
-0.31%-2.04%-17.72%-17.63% 51.72B
-1.15%+4.50%-7.84%-52.07% 30.35B
-0.07%+4.10%-25.40%-30.86% 20.29B
-0.14%+0.33%+15.07%+6.78% 19.7B
-3.43%+1.40%-4.39%+20.70% 18.55B
-0.16%+1.03%-15.48%+4.89% 11.47B
Average -0.78%+1.13%-6.84%-7.49% 73.58B
Weighted average by Cap. -0.46%+0.01%-5.01%-5.88%

Financials

2026 *2027 *
Net sales 15.63B 13.58B 12.64B 11.61B 21.92B 1,492B 22.26B 149B 58.49B 743B 58.68B 57.39B 2,490B 16.02B 13.93B 12.96B 11.9B 22.48B 1,529B 22.82B 153B 59.97B 761B 60.17B 58.85B 2,553B
Net income 1.84B 1.6B 1.49B 1.37B 2.59B 176B 2.63B 17.58B 6.9B 87.58B 6.92B 6.77B 294B 2.06B 1.79B 1.67B 1.53B 2.9B 197B 2.94B 19.69B 7.73B 98.13B 7.75B 7.58B 329B
Net Debt 7.41B 6.44B 5.99B 5.5B 10.39B 707B 10.55B 70.64B 27.72B 352B 27.82B 27.2B 1,180B 6.81B 5.92B 5.51B 5.06B 9.55B 650B 9.7B 64.96B 25.49B 324B 25.58B 25.02B 1,085B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-07-31 US$19.24 -0.36% 22,744,382
26-07-30 US$19.31 -2.43% 16,297,221
26-07-29 US$19.79 +0.20% 27,193,670
26-07-28 US$19.75 +1.39% 19,625,025
26-07-27 US$19.48 +1.04% 20,910,019
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
19.24USD
Average target price
19.83USD
Spread / Average Target
+3.08%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock